As of 2024-12-12, the Intrinsic Value of Titan Medical Inc (TMD.TO) is
3.31 CAD. This TMD.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 0.80 CAD, the upside of Titan Medical Inc is
313.90%.
The range of the Intrinsic Value is 2.66 - 4.45 CAD
TMD.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
2.66 - 4.45 |
3.31 |
313.9% |
| DCF (Growth 10y) |
3.08 - 5.09 |
3.81 |
376.7% |
| DCF (EBITDA 5y) |
4.94 - 6.47 |
5.67 |
608.1% |
| DCF (EBITDA 10y) |
4.81 - 6.84 |
5.73 |
616.1% |
| Fair Value |
-0.81 - -0.81 |
-0.81 |
-200.93% |
| P/E |
(6.21) - 8.48 |
0.98 |
22.2% |
| EV/EBITDA |
(1.76) - 6.02 |
1.86 |
132.3% |
| EPV |
(5.04) - (7.53) |
(6.29) |
-885.6% |
| DDM - Stable |
(1.13) - (2.58) |
(1.86) |
-332.3% |
| DDM - Multi |
1.99 - 3.70 |
2.60 |
225.5% |
TMD.TO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
35.40 |
| Beta |
1.41 |
| Outstanding shares (mil) |
44.25 |
| Enterprise Value (mil) |
31.44 |
| Market risk premium |
5.10% |
| Cost of Equity |
8.30% |
| Cost of Debt |
5.00% |
| WACC |
8.13% |